AEON Biopharma AEON
NYSE AEON
$0.24 +0.00 (+2.03%)
As of: Oct 20, 2026 · 2:55 PM EDT

AEON Biopharma (AEON) Notes Payables (2020 - 2023)

Updated

AEON Biopharma (AEON) posted Notes Payables of $1 million for Q2 2024, up 566.7% from the prior quarter.

Analysis

AEON Biopharma (AEON) Notes Payables (2020 - 2023) Analysis & Trends

At the end of FY2022, AEON Biopharma's Notes Payables came in at $70.87 million.

  • In prior years, AEON Biopharma's Notes Payables was $38,588 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,149.75 Bn 1,118.34 Bn 19.71 Bn
2 Johnson & Johnson 623.95 Bn 542.48 Bn 17.26 Bn
3 AbbVie 509.37 Bn 482.48 Bn 12.70 Bn
4 Merck 366.05 Bn 320.43 Bn 12.21 Bn
5 Novartis Ag 297.67 Bn 261.66 Bn 11.24 Bn
6 Astrazeneca 261.57 Bn 235.26 Bn 12.86 Bn
7 Amgen 235.98 Bn 191.38 Bn 7.24 Bn
8 Gilead Sciences 194.26 Bn 168.45 Bn 6.22 Bn
9 Pfizer 171.94 Bn 118.58 Bn 10.94 Bn
10 AEON Biopharma 11.91 Mn -8.89 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 1.00 Mn
Mar 31, 2023 150,000.00
Dec 31, 2022 70.87 Mn
Mar 31, 2021 203,817.00
Dec 31, 2020 38,588.00
API Access

AEON Biopharma Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=AEON&period=max&api_key=YOUR_API_KEY